The altered transcriptome of pediatric myelodysplastic syndrome revealed by RNA sequencing
Lorena Zubovic1, Silvano Piazza2, Toma Tebaldi3
1Laboratory of Molecular and Cellular Neurobiology, Department of Cellular, Computational and Integrative Biology - CIBIO, University of Trento, Trento, Italy. lorena.zubovic@unitn.it.
Abstract:
Pediatric myelodysplastic syndrome (PMDS) is a very rare and still poorly characterized disorder. In this work, we identified novel potential targets of PMDS by determining genes with aberrant expression, which can be correlated with PMDS pathogenesis. We identified 291 differentially expressed genes (DEGs) in PMDS patients, comprising genes involved in the regulation of apoptosis and the cell cycle, ribosome biogenesis, inflammation and adaptive immunity. Ten selected DEGs were then validated, confirming the sequencing data. These DEGs will potentially represent new molecular biomarkers and therapeutic targets for PMDS.
Insights
Pediatric myelodysplastic syndrome (PMDS) is a rare disorder. Researchers identified 291 differentially expressed genes (DEGs) in PMDS, offering potential new biomarkers and therapeutic targets for this condition.
Area of Science:
- Hematology
- Genetics
- Molecular Biology
Background:
- Pediatric myelodysplastic syndrome (PMDS) is a rare and poorly understood hematologic disorder.
- Identifying molecular mechanisms underlying PMDS is crucial for developing effective treatments.
Discussion:
- This study identified 291 differentially expressed genes (DEGs) in pediatric myelodysplastic syndrome (PMDS) patients.
- These DEGs are implicated in critical cellular processes including apoptosis, cell cycle regulation, ribosome biogenesis, and immune responses.
- Validation of ten selected DEGs confirms the reliability of the sequencing data.
Key Insights:
- Aberrant gene expression patterns are linked to PMDS pathogenesis.
- Identified DEGs provide novel insights into the molecular underpinnings of PMDS.
- The validated DEGs show promise as potential diagnostic biomarkers and therapeutic targets.
Outlook:
- Further research into the functional roles of these DEGs could elucidate PMDS mechanisms.
- These findings may pave the way for targeted therapies and improved diagnostic strategies for pediatric patients.
- This study contributes to a better characterization of PMDS, potentially improving patient outcomes.
Related Concept Videos
RNA-seq
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing


